Stock Quotes in this Article: AMPE, ECTE, RGDX, BAXS

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

>>5 Active Trades for a Quiet Month

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

>>5 Stocks With Big Insider Buying

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Echo Therapeutics

Echo Therapeutics (ECTE) operates as a transdermal medical device company in the U.S. This stock closed up 2.4% to $3.72 a share in Thursday's trading session.

Thursday's Range: $3.59-$3.85

52-Week Range: $1.80-$14.50

Thursday's Volume: 178,000

Three-Month Average Volume: 563,173

>>5 Rocket Stocks to Stomp the S&P in 2014

From a technical perspective, ECTE bounced modestly higher here right off its 200-day moving average of $3.52 with lighter-than-average volume. This move is starting to push shares of ECTE within range of triggering a near-term breakout trade. That trade will hit if ECTE manages to take out Thursday's high of $3.85 to some more near-term overhead resistance at $4.13 with high volume.

Traders should now look for long-biased trades in ECTE as long as it's trending above some near-term support at $3.22 or above its 50-day at $3.04 and then once it sustains a move or close above those breakout levels with volume that hits near or above 563,173 shares. If that breakout hits soon, then ECTE will set up to re-test or possibly take out its next major overhead resistance levels at $4.91 to $6.

Ampio Pharmaceuticals

Ampio Pharmaceuticals (AMPE), a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of pharmaceutical drugs and diagnostic products to identify, treat, and prevent metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction This stock closed up 6.4% to $9.24 in Thursday's trading session.

Thursday's Range: $8.60-$9.35

52-Week Range: $3.60-$10.86

Thursday's Volume: 446,000

Three-Month Average Volume: 391,989

>>4 Stocks Spiking on Big Volume

From a technical perspective, AMPE spiked sharply higher here right off some near-term support at $8.50 with above-average volume. This stock has been uptrending strong for the last month and change, with shares moving higher from its low of $6.41 to its recent high of $9.80. During that uptrend, shares of AMPE have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of AMPE within range of triggering a big breakout trade. That trade will hit if AMPE manages to take out Thursday's high of $9.35 and then once it clears some more key overhead resistance levels at $9.80 at $9.95 with high volume

Traders should now look for long-biased trades in AMPE as long as it's trending above some key near-term support at $8.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 391,989 shares. If that breakout hits soon, then AMPE will set up to re-test or possibly take out its 52-week high at $10.86.

Baxano Surgical

Baxano Surgical (BAXS), a medical device company, designs, develops, and markets minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. This stock closed up 5.8% to $1.27 in Thursday's trading session.

Thursday's Range: $1.16-$1.29

52-Week Range: $0.92-$2.67

Thursday's Volume: 563,000

Three-Month Average Volume: 340,859

From a technical perspective, BAXS jumped higher here right above its 50-day moving average of $1.08 with above-average volume. This move is starting to push shares of BAXS within range of triggering a near-term breakout trade. That trade will hit if BAXS manages to take out Thursday's high of $1.29 to $1.35 and then once it takes out some more key overhead resistance levels at $1.43 to $1.45 with high volume.

Traders should now look for long-biased trades in BAXS as long as it's trending above Thursday's low of $1.16 or above its 50-day at $1.08 and then once it sustains a move or close above those breakout levels with volume that hits near or above 340,859 shares. If that breakout hits soon, then BAXS will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $1.66 to $1.85, or even $2.

Response Genetics

Response Genetics (RGDX), a life science company, engages in the research, development, marketing, and sale of pharmacogenomic tests for use in the treatment of cancer primarily in the U.S., Asia, and Europe. This stock closed up 9.1% to $1.67 in Thursday's trading session.

Thursday's Range: $1.47-$1.68

52-Week Range: $1.09-$2.93

Thursday's Volume: 805,000

Three-Month Average Volume: 231,900

From a technical perspective, RGDX ripped sharply higher here back above its 200-day moving average at $1.66 with above-average volume. This stock has been uptrending strong for the last month, with shares soaring higher from its low of $1.09 to its intraday high of $1.68. During that move, shares of RGDX have been consistently making higher lows and higher highs, which is bullish technical price action.

Traders should now look for long-biased trades in RGDX as long as it's trending above Tuesday's low of $1.47 or above its 50-day at $1.32 and then once it sustains a move or close Thursday's high of $1.68 with volume that hits near or above 231,900 shares. If we get that move soon, then RGDX will set up to re-test or possibly take out its next major overhead resistance levels at $2 to $2.20, or even $2.45.

To see more stocks that are making notable moves higher, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.


RELATED LINKS:







Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com.

You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.